Register entry

Alpha Cognition, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
3
Live patents
12
Countries
0
Catalogue

Drug listings by form and route

3

3 active NDC listings: 3 human prescription drug. By marketing category: NDA 3.

Dosage formNDCs
tablet, delayed release3
RouteNDCs
oral3
Labeller name on the listingNDCs
alpha cognition, inc.3
Exclusivity

Patents and exclusivities

12
PatentProductCoversExpiry
9763953ZUNVEYLbenzgalantamine gluconateuseDec 2026
11795176ZUNVEYLbenzgalantamine gluconatesubstanceJan 2042
12208167ZUNVEYLbenzgalantamine gluconateproductFeb 2044
12551491ZUNVEYLbenzgalantamine gluconateuseJul 2045
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
ZUNVEYLbenzgalantaminetablet, delayed release, oral84054-005NDA
ZUNVEYLbenzgalantaminetablet, delayed release, oral84054-010NDA
ZUNVEYLbenzgalantaminetablet, delayed release, oral84054-015NDA
Enquiry

Common questions

Is Alpha Cognition, Inc. FDA approved?
Alpha Cognition, Inc. holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Alpha Cognition, Inc. make?
3 products are listed under Alpha Cognition, Inc. in the openFDA NDC Directory, most often as tablet, delayed release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.